中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 7
Jul.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(7): 1438-1445

Influencing factors for chronic pancreatitis complicated by pancreatogenic portal hypertension and establishment of a predictive model

DOI: 10.12449/JCH240723
  • 1.

    Department of Gastroenterology，The First Affiliated Hospital of Kunming Medical University，Yunnan Province Clinical Research Center for Digestive Diseases，Kunming 650032，China

  • 2.

    Department of Gastroenterology，Chuxiong Yi Autonomous Prefecture People’s Hospital，Chuxiong，Yunnan 675000，China

  • 3.

    Department of Gastroenterology，Wenshan People’s Hospital，Wenshan，Yunnan 663000，China

  • 4.

    Department of Gastroenterology，Puer People’s Hospital，Puer，Yunnan 665000，China

Research funding:

Yunnan Province Science and Technology Plan Project (202102AA100062)

More Information
  • Corresponding author: ZHANG Hairong， zhr919@sina.com （ORCID： 0000-0002-9918-3673）
  • Received Date: 2023-11-01
  • Accepted Date: 2023-12-21
  • Published Date: 2024-07-25
    Abstract
  •   Objective  To investigate the influencing factors for chronic pancreatitis （CP） complicated by pancreatogenic portal hypertension （PPH）， and to establish a predictive model.  Methods  A retrospective analysis was performed for the clinical data of 99 patients with CP complicated by PPH who were hospitalized in The First Affiliated Hospital of Kunming Medical University， Chuxiong Yi Autonomous Prefecture People’s Hospital， Wenshan People’s Hospital， and Puer People’s Hospital from January 2017 to December 2022， and these patients were enrolled as PPH group. The incidence density sampling method was used to select 198 CP patients from databases as control group. The independent-samples t test was used for comparison of normally distributed continuous data between two groups， and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups； the chi-square test or the Fisher’s exact test was used for comparison of categorical data between two groups. The Least Absolute Shrinkage and Selection Operator （LASSO） regression model was used to identify the potential predictive factors for CP complicated by PPH， and the predictive factors obtained were included in the multivariate Logistic regression analysis to obtain independent risk factors， which were used to establish a nomogram prediction model. The receiver operating characteristic （ROC） curve， the calibration curve， and the Hosmer-Lemeshow goodness-of-fit test were used to perform internal validation of the model， and the clinical decision curve was used to assess the clinical practicability of the model.  Results  There were significant differences between the two groups in sex， history of recurrent acute pancreatitis attacks， acute exacerbation of CP， bile duct stones， peripancreatic fluid accumulation， pseudocysts， pulmonary infection， elevated C-reactive protein （CRP）， elevated procalcitonin， fibrinogen （FIB）， neutrophil-lymphocyte ratio （NLR）， gamma-glutamyl transpeptidase， total bilirubin， direct bilirubin， low-density lipoprotein （LDL）， serum amylase， D-dimer， and serum albumin （all P<0.05）. The predictive variables obtained by the LASSO regression analysis included sex， recurrent acute pancreatitis attacks， bile duct stones， peripancreatic fluid accumulation， pulmonary infection， pseudocysts， CRP， NLR， FIB， and LDL. The multivariate Logistic regression analysis showed that sex （odds ratio ［OR］=2.716， P<0.05）， recurrent acute pancreatitis attacks （OR=2.138， P<0.05）， peripancreatic fluid accumulation （OR=2.297， P<0.05）， pseudocysts （OR=2.805， P<0.05）， and FIB （OR=1.313， P<0.05） were independent risk factors for CP complicated by PPH. The above factors were fitted into the model， and the Bootstrap internal validation showed that the nomogram model had an area under the ROC curve of 0.787 （95% confidence interval： 0.730 — 0.844）， and the calibration curve was close to the reference curve. The Hosmer-Lemeshow goodness-of-fit test showed that the model had a good degree of fitting （χ2=7.469， P=0.487）. The clinical decision curve analysis showed that the prediction model had good clinical practicability.  Conclusion  Male sex， recurrent acute pancreatitis attacks， peripancreatic fluid accumulation， pseudocysts， and FIB are independent risk factors for CP complicated by PPH， and the nomogram model established has good discriminatory ability， calibration， and clinical practicability.

     

    • FullText(HTML)
  • loading
    • References(34)
  • [1]
    Chronic Pancreatitis Group of Pancreatic Disease Committee of Chinese Medical Doctor Association. Guideline for the diagnosis and treatment of chronic pancreatitis(2018, Guangzhou)[J]. J Clin Hepatol, 2019, 35( 1): 45- 51. DOI: 10.3969/j.issn.1001-5256.2019.01.008.

    中国医师协会胰腺病专业委员会慢性胰腺炎专委会. 慢性胰腺炎诊治指南(2018, 广州)[J]. 临床肝胆病杂志, 2019, 35( 1): 45- 51. DOI: 10.3969/j.issn.1001-5256.2019.01.008.
    [2]
    ADAM U, MAKOWIEC F, RIEDIGER H, et al. Pancreatic head resection for chronic pancreatitis in patients with extrahepatic generalized portal hypertension[J]. Surgery, 2004, 135( 4): 411- 418. DOI: 10.1016/j.surg.2003.08.021.
    [3]
    RU N, HE CH, REN XL, et al. Risk factors for sinistral portal hypertension and related variceal bleeding in patients with chronic pancreatitis[J]. J Dig Dis, 2020, 21( 8): 468- 474. DOI: 10.1111/1751-2980.12916.
    [4]
    LATORRE FRAGUA RA, MANUEL VÁZQUEZ A, LÓPEZ MARCANO AJ, et al. Pancreatic surgery in chronic pancreatitis complicated by extrahepatic portal hypertension or cavernous transformation of the portal vein: A systematic review[J]. Scand J Surg, 2020, 109( 3): 177- 186. DOI: 10.1177/1457496919857260.
    [5]
    KUL M, NÜ HALILOĞLU, HÜRSOY N, et al. Sinistral portal hypertension: Computed tomography imaging findings and clinical appearance-a descriptive case series[J]. Can Assoc Radiol J, 2018, 69( 4): 417- 421. DOI: 10.1016/j.carj.2018.07.006.
    [6]
    PEREIRA P, PEIXOTO A. Left-sided portal hypertension: A clinical challenge[J]. GE Port J Gastroenterol, 2015, 22( 6): 231- 233. DOI: 10.1016/j.jpge.2015.10.001.
    [7]
    YU DJ, LI XL, GONG JP, et al. Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: A case report and literature review[J]. BMC Gastroenterol, 2020, 20( 1): 276. DOI: 10.1186/s12876-020-01420-x.
    [8]
    FERNANDES A, ALMEIDA N, FERREIRA AM, et al. Left-sided portal hypertension: A sinister entity[J]. GE Port J Gastroenterol, 2015, 22( 6): 234- 239. DOI: 10.1016/j.jpge.2015.09.006.
    [9]
    PATEL H, BHANDARI P, KUMAR K, et al. Isolated gastric varices due to essential thrombocytosis related to splenic vein thrombosis: A challenge to uncover the concealed diagnosis[J]. Cureus, 2019, 11( 11): e6068. DOI: 10.7759/cureus.6068.
    [10]
    ZHENG KX, GUO XZ, FENG J, et al. Gastrointestinal bleeding due to pancreatic disease-related portal hypertension[J]. Gastroenterol Res Pract, 2020, 2020: 3825186. DOI: 10.1155/2020/3825186.
    [11]
    XIE CL, WU CQ, CHEN Y, et al. Sinistral portal hypertension in acute pancreatitis: A magnetic resonance imaging study[J]. Pancreas, 2019, 48( 2): 187- 192. DOI: 10.1097/MPA.0000000000001242.
    [12]
    ZHAO YP, LI XB, LI HW, et al. Diagnosis and treatment guidelines for pancreatic portal hypertension(draft)[J]. Chin J Gen Surg, 2013, 28( 5): 405- 406. DOI: 10.3760/cma.j.issn.1007-631X.2013.05.032.

    赵玉沛, 李晓斌, 李宏为, 等. 胰源性门静脉高压症诊治规范(草案)[J]. 中华普通外科杂志, 2013, 28( 5): 405- 406. DOI: 10.3760/cma.j.issn.1007-631X.2013.05.032.
    [13]
    TALAGALA IA, NAWARATHNE M, ARAMBEPOLA C. Novel risk factors for primary prevention of oesophageal carcinoma: A case-control study from Sri Lanka[J]. BMC Cancer, 2018, 18( 1): 1135. DOI: 10.1186/s12885-018-4975-4.
    [14]
    KÖKLÜ S, ÇOBAN Ş, YÜKSEL O, et al. Left-sided portal hypertension[J]. Dig Dis Sci, 2007, 52( 5): 1141- 1149. DOI: 10.1007/s10620-006-9307-x.
    [15]
    PAN YM, XIE M, BAO SH, et al. The diagnosis and treatment of pancreatic segmental portal hypertension with upper gastrointestinal bleeding[J]. J Clin Hepatol, 2011, 27( 11): 1184- 1186. DOI: 10.3969/j.issn.1001-5256.2011.11.011.

    潘一明, 谢敏, 包善华, 等. 胰源性区域性门脉高压症合并上消化道出血的诊治分析[J]. 临床肝胆病杂志, 2011, 27( 11): 1184- 1186. DOI: 10.3969/j.issn.1001-5256.2011.11.011.
    [16]
    TU GP, SUN JC, LIU YF, et al. Clinical experience of pancreatitis causing regional portal hypertension of pancreatic origin[J]. J Hepatobiliary Surg, 2019, 27( 6): 418- 422. DOI: 10.3969/j.issn.1006-4761.2019.06.007.

    涂广平, 孙吉春, 刘云飞, 等. 胰腺炎引起胰源性区域性门脉高压临床诊疗经验探讨[J]. 肝胆外科杂志, 2019, 27( 6): 418- 422. DOI: 10.3969/j.issn.1006-4761.2019.06.007.
    [17]
    LI ZS, GUO HL. Progress in diagnosis and treatment of pancreatic portal hypertension[J]. J Hepatobiliary Surg, 2017, 25( 5): 325- 328. DOI: 10.3969/j.issn.1006-4761.2017.05.003.

    李兆申, 郭洪雷. 胰源性门脉高压症的诊治进展[J]. 肝胆外科杂志, 2017, 25( 5): 325- 328. DOI: 10.3969/j.issn.1006-4761.2017.05.003.
    [18]
    KININY W EL, KEARNEY L, HOSAM N, et al. Recurrent variceal haemorrhage managed with splenic vein stenting[J]. Ir J Med Sci, 2017, 186( 2): 323- 327. DOI: 10.1007/s11845-016-1420-z.
    [19]
    IRAWAN H, MULYAWAN IM. Combination of modified Sugiura technique and proximal splenorenal shunt for the management of portal vein thrombosis in noncirrhotic portal hypertension[J]. Clin Exp Gastroenterol, 2019, 12: 149- 156. DOI: 10.2147/CEG.S188200.
    [20]
    WANI ZA, BHAT RA, BHADORIA AS, et al. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification[J]. Saudi J Gastroenterol, 2015, 21( 3): 129- 138. DOI: 10.4103/1319-3767.157550.
    [21]
    YU C, DING L, JIANG ML, et al. Dynamic changes and nomogram prediction for sinistral portal hypertension in moderate and severe acute pancreatitis[J]. Front Med, 2022, 9: 875263. DOI: 10.3389/fmed.2022.875263.
    [22]
    EASLER J, MUDDANA V, FURLAN A, et al. Portosplenomesenteric venous thrombosis in patients with acute pancreatitis is associated with pancreatic necrosis and usually has a benign course[J]. Clin Gastroenterol Hepatol, 2014, 12( 5): 854- 862. DOI: 10.1016/j.cgh.2013.09.068.
    [23]
    LI H, YANG ZY, TIAN F. Clinical characteristics and risk factors for sinistral portal hypertension associated with moderate and severe acute pancreatitis: A seven-year single-center retrospective study[J]. Med Sci Monit, 2019, 25: 5969- 5976. DOI: 10.12659/MSM.916192.
    [24]
    RAMSEY ML, CONWELL DL, HART PA. Complications of chronic pancreatitis[J]. Dig Dis Sci, 2017, 62( 7): 1745- 1750. DOI: 10.1007/s10620-017-4518-x.
    [25]
    BALAKRISHNAN V, UNNIKRISHNAN AG, THOMAS V, et al. Chronic pancreatitis. A prospective nationwide study of 1, 086 subjects from India[J]. JOP, 2008, 9( 5): 593- 600.
    [26]
    PANDEY V, PATIL M, PATEL R, et al. Prevalence of splenic vein thrombosis and risk of gastrointestinal bleeding in chronic pancreatitis patients attending a tertiary hospital in western India[J]. J Family Med Prim Care, 2019, 8( 3): 818- 822. DOI: 10.4103/jfmpc.jfmpc_414_18.
    [27]
    HAO L, PAN J, WANG D, et al. Risk factors and nomogram for pancreatic pseudocysts in chronic pancreatitis: A cohort of 1998 patients[J]. J Gastroenterol Hepatol, 2017, 32( 7): 1403- 1411. DOI: 10.1111/jgh.13748.
    [28]
    ZHANG C, LIN T, ZHANG JY, et al. Diagnosis and treatment of acute pancreatitis complicated with regional portal hypertension[J/OL]. Chin J Hepatic Surg Electron Ed, 2022, 11( 1): 48- 53. DOI: 10.3877/cma.j.issn.2095-3232.2022.01.011.

    张春, 林婷, 张靖垚, 等. 急性胰腺炎合并区域性门静脉高压症诊治分析[J/OL]. 中华肝脏外科手术学电子杂志, 2022, 11( 1): 48- 53. DOI: 10.3877/cma.j.issn.2095-3232.2022.01.011.
    [29]
    YANG Y, WANG YZ, LI YJ, et al. Analysis of risk factors for acute pancreatitis with thrombotic diseases[J]. Chin J Pancreatol, 2021, 21( 4): 258- 263. DOI: 10.3760/cma.j.cn115667-20210411-00076.

    杨颖, 王鵷臻, 李亚俊, 等. 急性胰腺炎并发血栓性疾病的危险因素分析[J]. 中华胰腺病杂志, 2021, 21( 4): 258- 263. DOI: 10.3760/cma.j.cn115667-20210411-00076.
    [30]
    LIU KJ, CHEN DF. Diagnosis and treatment of hypercoagulability in severe acute pancreatitis[J]. Chin J Pancreatol, 2017, 17( 2): 73- 76. DOI: 10.3760/cma.j.issn.1674-1935.2017.02.001.

    刘凯军, 陈东风. 重症急性胰腺炎血液高凝状态的诊断和治疗[J]. 中华胰腺病杂志, 2017, 17( 2): 73- 76. DOI: 10.3760/cma.j.issn.1674-1935.2017.02.001.
    [31]
    MACHLUS KR, CARDENAS JC, CHURCH FC, et al. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice[J]. Blood, 2011, 117( 18): 4953- 4963. DOI: 10.1182/blood-2010-11-316885.
    [32]
    WOLBERG AS, SANG YQ. Fibrinogen and factor XIII in venous thrombosis and Thrombus stability[J]. Arterioscler Thromb Vasc Biol, 2022, 42( 8): 931- 941. DOI: 10.1161/ATVBAHA.122.317164.
    [33]
    FEI Y, GAO K, HU J, et al. Predicting the incidence of portosplenomesenteric vein thrombosis in patients with acute pancreatitis using classification and regression tree algorithm[J]. J Crit Care, 2017, 39: 124- 130. DOI: 10.1016/j.jcrc.2017.02.019.
    [34]
    TOQUÉ L, HAMY A, HAMEL JF, et al. Predictive factors of splanchnic vein thrombosis in acute pancreatitis: A 6-year single-center experience[J]. J Dig Dis, 2015, 16( 12): 734- 740. DOI: 10.1111/1751-2980.12298.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (311) PDF downloads(26) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return